ATXI

0.30000.00%
CG

Curtis G. Oltmans

Chief Legal Officer, Head of External Affairs & Corporate Secretary

Mr. Curtis G. Oltmans, also known as Curt, J.D, serves as Independent Director at Avenue Therapeutics, Inc since April 01, 2021. He has experience in corporate law including senior management positions in legal departments at several leading pharmaceutical and biotechnology companies. He serves as Corporate Secretary at Fulcrum Therapeutics, Inc. since November 30, 2020 and serves as its Chief Legal Officer since 2022 and served as its General Counsel and serves as its Head of External Affairs since 2026 and was it Senior Vice President until 2026 since November 30, 2020 until 2022. He joined Fulcrum Therapeutics, Inc. in November 2020. Mr. Oltmans served as Executive Vice President and General Counsel of Array BioPharma Inc. since August 15, 2017 until March 19, 2019 and served its Secretary since August 2017 until March 19, 2019, where he oversaw all legal, corporate governance, patent and compliance matters. Mr. Oltmans served as Vice President and Head of Litigation at DaVita Kidney Care, Inc., where he was responsible for strategy and initiatives in the areas of law, including litigation, employee safety and insurance. Mr. Oltmans has deep experience on legal matters related to commercialization, litigation, medical, regulatory affairs, intellectual property, corporate governance, mergers and acquisitions, strategic alliances and financial transactions. He served as Corporate Vice President and General Counsel at Novo Nordisk, Inc. from December 2012 to 2017. He was responsible for strategy and initiatives in the areas of law, quality, intellectual property, grants and philanthropy for its business in North America and was responsible for strategic support in areas including market access, government affairs, communications and product marketing. Previously, he served as Vice President and Deputy General Counsel of Oltmans lead the Legal Affairs team. Mr. Oltmans was tapped in 2010 to led Novo Nordisk's Native American Health Initiative, a project designed to build sustainable diabetes care and education programs with the Rosebud Sioux Tribe in Rosebud, South Dakota. He joined Novo Nordisk in June 2005. Prior to Novo Nordisk, he held various positions at Eli Lilly and Company from 1992 to 2005, in a variety of legal roles, including litigation, FDA regulatory and international law. He has also served as Assistant General Counsel for Eli Lilly and Company after beginning his legal career supporting clients in pharmaceutical and medical device litigation matters. He served as an Associate at Shook, Hardy & Bacon in Kansas City, Missouri from 1989 to 1992, as well as a visiting associate at Cameron McKenna from 1988 to 1989 in London, UK. He is active in the local community, serving on Board of Directors for the Boys & Girls Club of Trenton & Mercer County. He has pharmaceutical industry experience. Mr. Oltmans holds a Bachelor of Arts in political science from the University of Nebraska in 1985 and Juris Degree from the University of Nebraska College of Law.

Positions